Incidence of and factors associated with brimonidine allergy
Approximately 5.5% of brimonidine users developed brimonidine allergy, which typically manifested at 32 weeks. Concurrent artificial tear and tafluprost use increased brimonidine allergy risk, whereas topical steroids' concomitant use reduced the risk.
Authors
- Rath Itthipanichpong (ORCID: https://orcid.org/0000-0003-1580-7870)
- Sunee Chansangpetch (ORCID: https://orcid.org/0000-0002-8996-2868)
- Pattawee Pongpisitkul
- Prin Rojanapongpun
- Kitiya Ratanawongphaibul (ORCID: https://orcid.org/0000-0002-4743-5189)
- Visanee Tantisevi (ORCID: https://orcid.org/0000-0003-3802-7586)
- Anita Manassakorn (ORCID: https://orcid.org/0000-0001-7483-8656)
- Kongkiart Tipparut
Institutions
- Thai Red Cross Society (TH)
- Chulalongkorn University (TH)
- King Chulalongkorn Memorial Hospital (TH)
Publication Details
- Journal
- PLoS ONE
- Published
- 2025-06-02
- DOI
- https://doi.org/10.1371/journal.pone.0325319
- Citations
- 1
- Primary Topic
- Allergic Rhinitis and Sensitization
- Type
- article
- Field-Weighted Citation Impact
- 1.62